BGLCBioNexus Gene Lab Corp同业对比
BioNexus Gene Lab Corp 与SIC 8071 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BGLC本股 | $4M#8 | — | 0.5x#5 | 0.5x#2 | -21.9%#10 | -86.7%#12 | -39.9%#7 | -38.4%#6 | — | — | -75.7%#4 | — |
| FLGT | $566M#1 | — | 0.6x#6 | 1.8x#4 | 13.8%#6 | -41.7%#10 | -28.2%#5 | -6.0%#3 | — | — | — | — |
| BDSX | $249M#2 | — | 27.2x#8 | 2.8x#5 | 24.1%#4 | 17.8%#6 | -31.5%#6 | -385.7%#10 | -95.6%#3 | — | 260.5%#1 | — |
| XGN | $208M#3 | — | 17.0x#7 | 3.1x#6 | 19.7%#5 | -32.0%#9 | -21.1%#4 | -163.3%#9 | -134.4%#4 | 2#2 | — | — |
| FRNM | $111M#4 | — | — | — | — | — | — | — | — | — | 18.1%#2 | — |
| AMS | $8M#5 | — | 0.4x#3 | 0.3x#1 | -0.9%#8 | -171.0%#13 | -12.8%#3 | -6.7%#4 | -21.2%#2 | 4#1 | — | — |
| ACON | $6M#6 | — | 0.3x#2 | 73.1x#8 | 65.6%#2 | -3.4%#7 | -9312.5%#11 | -42.5%#7 | — | — | — | — |
| ADVB | $5M#7 | 0.5x#1 | 0.4x#4 | 36.6x#7 | — | 304.9%#1 | -4883.8%#10 | 54.4%#1 | — | — | -75.5%#3 | — |
| ACONW | $73789#9 | — | 0.0x#1 | 1.0x#3 | 65.6%#2 | -3.4%#7 | -9312.5%#11 | -42.5%#7 | — | — | — | — |
| BNR | — | — | — | — | 9.2%#7 | 83.3%#3 | -10.2%#2 | -10.3%#5 | — | — | — | — |
| CFOR | — | — | — | — | 481.2%#1 | 96.9%#2 | 79.6%#1 | 31.8%#2 | 26.3%#1 | — | — | — |
| FCHS | — | — | — | — | -9.6%#9 | -80.9%#11 | -254.8%#8 | — | — | — | — | — |
| LUDG | — | — | — | — | — | 25.9%#5 | -817824.9%#13 | — | — | — | — | — |
| RENXF | — | — | — | — | -32.7%#11 | 26.6%#4 | -1293.5%#9 | — | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-02。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议